RESUMEN
Background@#Retinoblastoma is the most common intraocular cancer in childhood in the Philippines. Most data though on demographics, clinical profile, treatment options, and outcomes in the country are from the National Capital Region. @*Objectives@#This study aimed to describe the demographics, clinical profile, treatment done, and outcomes of retinoblastoma patients seen in a public tertiary referral center in Davao from 2011-2020 to make available literature more representative of the status of retinoblastoma in the Philippines. @*Methods@#An analytical cross-sectional study was conducted using the records of retinoblastoma patients seen in a tertiary government hospital located in Davao Region from January 2011 to December 2020. @*Results@#There were 157 patients included in the analysis. Seventy-three (46%) were female with 44% coming from the Davao Region. One hundred seven (69%) patients had unilateral disease. Median age at initial consultation for patients with unilateral disease was significantly older than those with bilateral disease (p<0.003). Tumors were extraocular in 82 (40%) eyes. In the intraocular group, 36% of the eyes belonged to International Classification of Retinoblastoma (ICRB) Groups D and E. Enucleation was the most commonly performed treatment. Survival rate was 28%. This is the first report to provide epidemiologic and clinical data on retinoblastoma in the literature, including survival data, from Mindanao. Advanced stages and extraocular cases of retinoblastoma remain high. Delay of consultation contributed to the prognosis and clinical outcome of the disease.@*@#Conclusion. Advanced stages and extraocular cases of retinoblastoma remain significantly high in the country, even in Mindanao.
Asunto(s)
Retinoblastoma , Terapéutica , Tasa de SupervivenciaRESUMEN
Introducción: El cáncer de laringe es el tumor maligno de mayor prevalencia en la Otorrinolaringología. La topografía glótica es la más frecuente en Uruguay y suele detectarse en estadios tempranos dada la manifestación precoz y sostenida de disfonía. El objetivo de este estudio es describir la sobrevida libre de enfermedad (SLE) y la sobrevida global (SG) de los pacientes con cáncer de laringe glótico en estadio T1N0M0 en 4 instituciones de Montevideo. Metodología: Se analizó de forma retrospectiva la SG y SLE de 55 pacientes diagnosticados con cáncer de glotis T1 entre los años 2009 y 2019. Para el cálculo de la sobrevida se utilizó el método de Kaplan-Meier. Se estudió además el efecto de variables pronósticas de interés sobre la SG mediante análisis univariado y multivariado. Resultados: En la muestra analizada la SG de los pacientes con cáncer glótico T1N0M0 fue como media de 7.706 años (IC 95% 6.63 - 8.78). A los 5 años, la SG fue de 77.5% (± 7%) y de 62% (± 9.8%) a los 10 años. La SLE para todos los pacientes correspondió al 74.6% (± 7.5%) y 63.1% (± 9.8%), a 5 y 10 años respectivamente. No se alcanzaron las medianas de SG ni de SLE para los grupos. Conclusiones: Los valores de SG y SLE medios obtenidos en nuestro medio son comparables a los valores reportados en la bibliografía internacional. No se alcanzó la mediana de SG ni de SLE, por lo que se puede afirmar que ésta enfermedad tiene, cuando se realiza el tratamiento adecuado, un buen pronóstico vital a los 10 años. Se requiere un seguimiento más largo para determinar las medianas de SG y SLE de los grupos en estudio.
Introduction: Laryngeal cancer is the most prevalent malignant tumor in Otorhinolaryngology. Glottic topography is the most frequent in Uruguay and is usually detected in early stages given the early and sustained manifestation of dysphonia. The objective of this study is to analyze disease-free survival (DFS) and overall survival (OS) of patients with stage T1N0M0 glottic laryngeal cancer at 4 institutions in Montevideo. Methodology: The mean OS and DFS of 55 patients diagnosed with T1 glottic cancer between 2009 and 2019 were retrospectively analyzed. Kaplan-Meier method was used to calculate survival. The prognostic effect of certain variables of interest on OS was also studied using univariate and multivariate analysis. Results: In this study, mean odds survival (OS) for T1N0M0 glottic cancer was 7.706 years (CI 95% 6.63 - 8.78). At 5 years, OS was 77.5% (± 7%) and at 10 years was 62% (± 9.8%). Disease free survival (DFS) was 74.6% ± (7.5%) at 5 years and 63.1% (± 9.8%), at 10 years. Median OS and DFS for the groups were not reached. Conclusions: OS and DFS in our medium is comparable to that reported in the international literature. The median OS and DFS were not reached, so it can be stated that this disease has, when appropriate treatment is performed, a good vital prognosis at 10 years. Longer follow-up is required to determine the median OS and DFS of the study groups.
Introdução: O câncer de laringe é o tumor maligno mais prevalente na Otorrinolaringologia. A topografia glótica é a mais frequente no Uruguai e geralmente é detectada em estágios iniciais devido à manifestação precoce e sustentada da disfonia. O objetivo deste estudo é analisar a sobrevida livre de doença (DFS) e a sobrevida global (OS) de pacientes com câncer de laringe glótico estágio T1N0M0 em 4 instituições em Montevidéu. Metodologia: Foram analisados retrospectivamente o OS e DFS de 55 pacientes diagnosticados com câncer glótico T1 entre 2009 e 2019. O método de Kaplan-Meier foi usado para calcular a sobrevida. Resultados: Na amostra, a sobrevida global (OS) do câncer glótico T1N0M0 foi em média de 7.706 anos (IC 95% 6,63 - 8,78). Aos 5 anos, a OS foi de 77,5% (± 7%) e 62% (± 9,8%) aos 10 anos. A DFS para todos os pacientes correspondeu a 74,6% (± 7,5%) e 63,1% (± 9,8%), aos 5 e 10 anos, respectivamente. As medianas de OS e DFS para os grupos não foram alcançadas. Conclusões: OS e DFS em nosso ambiente é comparável ao relatado na literatura internacional. As medianas de SG e SLD não foram alcançadas, pelo que se pode afirmar que esta doença apresenta, quando realizado tratamento adequado, um bom prognóstico vital aos 10 anos. É necessário um acompanhamento mais longo para determinar a mediana da SG e da SLD dos grupos de estudo.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Neoplasias Laríngeas/epidemiología , Uruguay/epidemiología , Análisis de Supervivencia , Tasa de Supervivencia , Estudios Retrospectivos , Supervivencia sin Enfermedad , Distribución por Edad y Sexo , OctogenariosRESUMEN
A sobrevivência ao câncer de mama é um problema de saúde pública que demanda serviços especializados com foco na reabilitação psicossocial. Entre as necessidades identificadas nesse contexto está o incentivo à adoção de estratégias de promoção de autocuidados pelas mulheres. Uma das estratégias adotadas consiste no grupo de apoio psicológico, que auxilia as pacientes a enfrentar a longa jornada do tratamento. Assim, o objetivo deste estudo é compreender os significados produzidos por mulheres com câncer de mama sobre sua participação em um grupo de apoio. Trata-se de um estudo qualitativo, descritivo e exploratório realizado com dez mulheres com câncer de mama usuárias de um serviço de reabilitação para mastectomizadas. Como referencial metodológico foi utilizada a Teoria Fundamentada nos Dados. A coleta de dados foi realizada por meio de entrevista aberta em profundidade e os conteúdos foram transcritos e codificados. A análise indutiva e o método de comparação constante foram aplicados nos processos de codificação aberta, axial e seletiva, que permitiram identificar três categorias nucleares: percepção das atividades realizadas no grupo, identificação de benefícios e barreiras do convívio no grupo e transformações decorrentes da participação. As participantes significaram sua presença no grupo como fonte de acolhimento, apoio, desenvolvimento de recursos pessoais e amizades, contribuindo para promover sua qualidade de sobrevida. Além dos potenciais benefícios, também foram identificadas barreiras que podem dificultar a adesão e continuidade da participação no grupo, o que sugere a necessidade de incorporar no cuidado um olhar para as dimensões subjetivas da saúde da mulher.(AU)
Surviving breast cancer is a public health problem and depends on services focused on psychosocial rehabilitation. Healthcare providers must encourage women to adopt strategies to promote their self-care. The psychological support group is a resource that helps women to face the long journey of treatment. This study aimed to understand the meanings women with breast cancer produced about their participation in a support group. This exploratory cross-sectional study was carried out with 10 women with breast cancer who use a rehabilitation service for mastectomized patients. Grounded Theory was used as a methodological reference. An open in-depth interview was applied for data collection. The contents were transcribed and coded. Inductive analysis and the constant comparison method were applied in the open, axial, and selective coding processes, which enabled the identification of three core categories: perception of the activities carried out in the group, identification of benefits and barriers of living in the group, and transformations resulting from participation. Participants denote their involvement with the group as a source of shelter, support, development of personal resources and friendships that helps promoting quality of life. Besides these potential benefits, participants also evinced barriers that can hinder adherence and continuity of participation in the group, suggesting the importance of incorporating a look at the subjective dimensions of women's health into care.(AU)
Sobrevivir al cáncer de mama es un problema de salud pública que depende de los servicios centrados en la rehabilitación psicosocial. Entre las necesidades identificadas en esta materia se encuentra el uso de estrategias para promover el autocuidado. Uno de los recursos que ayuda a afrontar el largo camino del tratamiento es el grupo de apoyo psicológico. El objetivo de este estudio es conocer los significados que producen las mujeres con cáncer de mama sobre su participación en un grupo de apoyo. Se trata de un estudio cualitativo, descriptivo y exploratorio, realizado con diez mujeres con cáncer de mama usuarias de un servicio de rehabilitación para mastectomizadas. Como referencia metodológica se utilizó la teoría fundamentada en los datos. Se aplicó una entrevista abierta en profundidad para la recogida de datos, cuyos contenidos fueron transcritos y codificados. El análisis inductivo y el método de comparación constante se aplicaron en los procesos de codificación abierta, axial y selectiva, lo que permitió identificar tres categorías centrales: percepción de las actividades realizadas en el grupo, identificación de los beneficios y las barreras de vivir en el grupo y transformaciones resultantes de la participación. Las mujeres denotan su participación en el grupo como una fuente de acogida, apoyo, desarrollo de recursos personales y amistades, que ayuda a promover la calidad de vida. Además de los beneficios potenciales, también se identificaron barreras que pueden dificultar la adherencia y continuidad de la participación en el grupo, lo que sugiere la necesidad de incorporar en la atención una mirada centrada en las dimensiones subjetivas de la salud de las mujeres.(AU)
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Anciano , Psicoterapia de Grupo , Grupos de Autoayuda , Neoplasias de la Mama , Salud Mental , Teoría Fundamentada , Enfermería Oncológica , Ansiedad , Trastornos de Ansiedad , Procesos Patológicos , Grupo de Atención al Paciente , Satisfacción Personal , Examen Físico , Psicología , Desempeño Psicomotor , Radioterapia , Relajación , Religión , Autocuidado , Unidades de Autocuidado , Autoimagen , Trastornos del Sueño-Vigilia , Responsabilidad Social , Apoyo Social , Socialización , Factores Socioeconómicos , Estrés Fisiológico , Concienciación , Yoga , Terapias Complementarias , Enfermedades de la Mama , Actividades Cotidianas , Instituciones Oncológicas , Aflicción , Servicios de Salud para Mujeres , Pesar , Mamografía , Biomarcadores , Ejercicio Físico , Mastectomía Segmentaria , Familia , Terapia Cognitivo-Conductual , Tasa de Supervivencia , Factores de Riesgo , Morbilidad , Mortalidad , Rango del Movimiento Articular , Autoexamen , Resultado del Tratamiento , Trastorno de Pánico , Mamoplastia , Autoexamen de Mamas , Atención Integral de Salud , Meditación , Quimioprevención , Vida , Implantación de Mama , Ingenio y Humor , Terapia Neoadyuvante , Terapia de Reemplazo de Hormonas , Libre Elección del Paciente , Intervención en la Crisis (Psiquiatría) , Quistes , Autonomía Personal , Muerte , Difusión de la Información , Comunicación Interdisciplinaria , Herencia , Depresión , Trastorno Depresivo , Diagnóstico , Quimioterapia , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Emociones , Terapia Familiar , Detección Precoz del Cáncer , Fatiga , Resiliencia Psicológica , Fertilidad , Terapia Molecular Dirigida , Catastrofización , Quimioradioterapia , Coraje , Ajuste Emocional , Autocontrol , Dolor en Cáncer , Estilo de Vida Saludable , Oncología Quirúrgica , Sistemas de Apoyo Psicosocial , Supervivencia , Psicooncología , Mentalización , Crecimiento Psicológico Postraumático , Tristeza , Regulación Emocional , Distrés Psicológico , Ejercicio Preoperatorio , Terapia Basada en la Mentalización , Apoyo Familiar , Bienestar Psicológico , Habilidades de Afrontamiento , Agotamiento Emocional , Promoción de la Salud , Salud Holística , Servicios Técnicos en Hospital , Inmunoterapia , Actividades Recreativas , Acontecimientos que Cambian la Vida , Estilo de Vida , Mastectomía , Oncología Médica , Trastornos Mentales , Estadificación de NeoplasiasRESUMEN
Introducción: el trasplante pulmonar se ha consolidado en los uÌltimos anÌos como una opcioÌn terapeÌutica para ninÌos y adolescentes con enfermedad pulmonar grave en la que han fracasado otros tratamientos. Este procedimiento otorga una buena calidad de vida y una supervivencia prolongada, similar a la del trasplante realizado en pacientes adultos. La indicacioÌn general para el trasplante pulmonar es la insuficiencia respiratoria progresiva, y potencialmente letal, debida a una enfermedad pulmonar parenquimatosa o vascular. La selección de candidatos a trasplante es compleja, requiriendo condiciones médicas y socioambientales específicas. Objetivos: analizar las características clínicas de los pacientes pediátricos con enfermedades pulmonares crónicas derivados para evaluación por el equipo de trasplante pulmonar de Uruguay. Analizar las características clínicas y sobrevida de los pacientes trasplantados pulmonares pediátricos uruguayos. Material y métodos: estudio descriptivo y retrospectivo de todos los pacientes menores de 19 años derivados al equipo de trasplante pulmonar entre 2003 y 2023. Datos obtenidos de la base del programa y mediante revisión de historias clínicas. Resultados: se incluyeron 30 pacientes (15 de sexo masculino). La media de edad de los pacientes derivados fue de 13,4 ± 3,6 años. Las etiologías de los pacientes derivados fueron 17/30 (56,6%) fibrosis quística, 4/30 (13,3%) bronquiolitis obliterante postrasplante de médula ósea, 4/30 (13,3%) hipertensión pulmonar, 3/30 (10%) bronquiolitis obliterante posinfecciosa y 2/30 (6,6%) enfermedad pulmonar intersticial difusa. Ingresaron en lista de trasplante 14 pacientes, de los cuales 9 se trasplantaron, 1 se mantiene en lista de espera y 4 fallecieron a la espera del trasplante. Del resto de los pacientes derivados para evaluación: 7 pacientes se encuentran aún en evaluación. Fueron excluidos por razones psicosociales o causas médicas 2 pacientes. Dos pacientes tuvieron pérdida de seguimiento y otros 5 fallecieron durante la evaluación. Las etiologías de los pacientes trasplantados pediátricos fueron fibrosis quística (3/9), bronquiolitis obliterante postrasplante de médula ósea (3/9) e hipertensión pulmonar (3/9). De los pacientes trasplantados, 5 fallecieron (2 en el posoperatorio y 3 fallecieron por sepsis entre 1-2 años postrasplante). Los restantes pacientes están en seguimiento postrasplante hace un mes, 2, 7 y 9 años. No se han encontrado diferencias estadísticamente significativas en la sobrevida condicional cuando se compararon pacientes adultos y pediátricos. Conclusiones: los resultados en los pacientes trasplantados en cuanto a caracteriÌsticas y causas de mortalidad son comparables con los reportados internacionalmente. La mortalidad postrasplante fue algo mayor que en otros estudios, pero creemos que existe sesgo por el bajo número de pacientes. Dados los resultados mencionados, planteamos que el trasplante sigue siendo una alternativa terapéutica válida en nuestro medio. Los desafíos de este tratamiento incluyen la disponibilidad limitada de órganos de donantes adecuados, la toxicidad de los medicamentos inmunosupresores necesarios para prevenir el rechazo, la prevención y el tratamiento de la bronquiolitis obliterante, así como maximizar el crecimiento, el desarrollo y la calidad de vida de los receptores.
Summary: Introduction: lung transplantation has been recently consolidated as a therapeutic option for children and adolescents with severe lung disease when other treatments have failed. This procedure provides a good quality of life and additional survival, similar to that of transplantation in adult patients. The general indication for lung transplantation is progressive, potentially fatal respiratory failure due to parenchymal or vascular lung disease. The selection of transplant candidates is complex, requiring specific medical and socio-environmental conditions. Objectives: to analyze the clinical characteristics of pediatric patients with chronic lung diseases referred for evaluation by the Uruguayan lung transplant team. To analyze the clinical characteristics and survival of Uruguayan pediatric lung transplant patients. Material and methods: descriptive and retrospective study of all patients under 19 years of age referred to the lung transplant team between 2003 and 2023. The data was obtained from the program's database and through medical records' review. Results: 30 patients were included (15 male). The mean age of the referred patients was 13.4 ± 3.6 years. Etiologies were 17/30 (56.6%) cystic fibrosis, 4/30 (13.3%) bronchiolitis obliterans post-bone marrow transplant, 4/30 (13.3%) pulmonary hypertension, 3 /30 (10%) post-infectious bronchiolitis obliterans, and 2/30 (6.6%) diffuse interstitial lung disease. 14 patients were placed on the transplant list, of which 9 were transplanted, 1 remains on the waiting list and 4 died while waiting for the transplant. Of the rest of the patients referred for evaluation: 7 patients are still under evaluation. 2 patients were excluded for psychosocial reasons or medical reasons. 2 patients could not be followed-up and other 5 died during the evaluation. The etiologies of the pediatric transplant patients were cystic fibrosis (3/9), post-bone marrow transplant bronchiolitis obliterans (3/9), and pulmonary hypertension (3/9). Of the transplanted patients, 5 died (two in the post-operative period, and three died from sepsis between 1-2 years post-transplant). The remaining patients are in post-transplant follow-up for 1 month, 2, 7 and 9 years. No statistically significant differences in conditional survival were found when comparing adult and pediatric patients. Conclusions: results in transplanted patients in terms of characteristics and causes of mortality are comparable with those reported internationally. Post-transplant mortality was somewhat higher than in other studies, but we believe that there is bias due to the low number of patients. Given the results above, we propose that transplantation continues to be a valid therapeutic alternative in our country. The challenges of this treatment include the limited availability of suitable donor organs, the toxicity of immunosuppressive medications necessary to prevent rejection, prevention and treatment of bronchiolitis obliterans, as well as maximizing the growth, development and quality of life of the receivers.
Introdução: o transplante pulmonar consolidou-se nos últimos anos como opção terapêutica para crianças e adolescentes com doença pulmonar grave, nas quais outros tratamentos falharam. Esse procedimento proporciona boa qualidade de vida e sobrevida prolongada, semelhante ao transplante realizado em pacientes adultos. A indicação geral para transplante pulmonar é insuficiência respiratória progressiva e potencialmente fatal devido a doença pulmonar parenquimatosa ou vascular. A seleção de candidatos a transplantes é complexa, exigindo condições médicas e socioambientais específicas. Objetivos: analisar as características clínicas de pacientes pediátricos com doenças pulmonares crônicas encaminhados para avaliação pela equipe uruguaia de transplante pulmonar. Analisar as características clínicas e a sobrevida de pacientes pediátricos uruguaios transplantados pulmonares. Material e métodos: estudo descritivo e retrospectivo de todos os pacientes menores de 19 anos encaminhados à equipe de transplante pulmonar entre 2003 e 2023. Os dados foram obtidos no banco de dados do programa e por meio de revisão de prontuários. Foram incluídos 30 pacientes (15 do sexo masculino). A média de idade dos pacientes encaminhados foi de 13,4 ± 3,6 anos. As etiologias dos pacientes encaminhados foram 17/30 (56,6%) fibrose cística, 4/30 (13,3%) bronquiolite obliterante pós-transplante de medula óssea, 4/30 (13,3%) hipertensão pulmonar, 3/30 (10%) pós -bronquiolite obliterante infecciosa e 2/30 (6,6%) doença pulmonar intersticial difusa. Foram colocados na lista de transplante 14 pacientes, dos quais 9 foram transplantados, 1 permanece em lista de espera e 4 faleceram enquanto aguardavam o transplante. Do restante dos pacientes encaminhados para avaliação: 7 pacientes ainda estão em avaliação, 2 pacientes foram excluídos por motivos psicossociais ou médicos. 2 pacientes foram perdidos no acompanhamento e outros 5 faleceram durante a avaliação. As etiologias dos pacientes transplantados pediátricos foram fibrose cística (3/9), bronquiolite obliterante pós-transplante de medula óssea (3/9) e hipertensão pulmonar (3/9). Dos pacientes transplantados, 5 faleceram (dois no pós-operatório e três por sepse entre 1-2 anos pós-transplante). Os demais pacientes estão em acompanhamento pós-transplante por 1 mês, 2, 7 e 9 anos. Não foram encontradas diferenças estatisticamente significativas na sobrevida condicional quando comparamos pacientes adultos e pediátricos. Conclusões: os resultados em pacientes transplantados em termos de características e causas de mortalidade são comparáveis aos relatados internacionalmente. A mortalidade pós-transplante foi um pouco maior do que em outros estudos, mas acreditamos que exista viés devido ao baixo número de pacientes. Diante dos resultados acima mencionados, propomos que o transplante continue sendo uma alternativa terapêutica válida em nosso meio. Os desafios deste tratamento incluem a disponibilidade limitada de órgãos de doadores adequados, a toxicidade dos medicamentos imunossupressores necessários para prevenir a rejeição, prevenção e tratamento da bronquiolite obliterante, bem como maximizar o crescimento, desenvolvimento e qualidade de vida dos receptores.
Asunto(s)
Humanos , Preescolar , Niño , Adolescente , Trasplante de Pulmón/estadística & datos numéricos , Enfermedades Pulmonares/cirugía , Derivación y Consulta , Uruguay/epidemiología , Enfermedad Crónica , Tasa de Supervivencia , Estudios Retrospectivos , Enfermedades Pulmonares/complicaciones , Enfermedades Pulmonares/epidemiologíaRESUMEN
BACKGROUND@#Lung cancer prevails and induces high mortality around the world. This study provided real-world information on the evolution of clinicopathological profiles and survival outcomes of lung cancer, and provided survival information within stage I subtypes.@*METHODS@#Patients pathologically confirmed with lung cancer between January 2009 and December 2018 were identified with complete clinicopathological information, molecular testing results, and follow-up data. Shifts in clinical characteristics were evaluated using χ2 tests. Overall survival (OS) was calculated through the Kaplan-Meier method.@*RESULTS@#A total of 26,226 eligible lung cancer patients were included, among whom 62.55% were male and 52.89% were smokers. Non-smokers and elderly patients took increasingly larger proportions in the whole patient population. The proportion of adenocarcinoma increased from 51.63% to 71.80%, while that of squamous carcinoma decreased from 28.43% to 17.60%. Gene mutations including EGFR (52.14%), KRAS (12.14%), and ALK (8.12%) were observed. Female, younger, non-smoking, adenocarcinoma patients and those with mutated EGFR had better survival prognoses. Importantly, this study validated that early detection of early-stage lung cancer patients had contributed to pronounced survival benefits during the decade. Patients with stage I lung cancer, accounted for an increasingly considerable proportion, increasing from 15.28% to 40.25%, coinciding with the surgery rate increasing from 38.14% to 54.25%. Overall, period survival analyses found that 42.69% of patients survived 5 years, and stage I patients had a 5-year OS of 84.20%. Compared with that in 2009-2013, the prognosis of stage I patients in 2014-2018 was dramatically better, with 5-year OS increasing from 73.26% to 87.68%. Regarding the specific survival benefits among stage I patients, the 5-year survival rates were 95.28%, 93.25%, 82.08%, and 74.50% for stage IA1, IA2, IA3, and IB, respectively, far more promising than previous reports.@*CONCLUSIONS@#Crucial clinical and pathological changes have been observed in the past decade. Notably, the increased incidence of stage I lung cancer coincided with an improved prognosis, indicating actual benefits of early detection and management of lung cancer.
Asunto(s)
Humanos , Masculino , Femenino , Anciano , Neoplasias Pulmonares/genética , Adenocarcinoma/patología , Pronóstico , Tasa de Supervivencia , Mutación , Receptores ErbB/genética , Estadificación de Neoplasias , Estudios RetrospectivosRESUMEN
Objective: To analyze the survival of nasopharyngeal carcinoma patients in Qidong from 1972 to 2016, and provide a basis for the prognosis evaluation and prevention for nasopharyngeal carcinoma patients. Methods: A total of 1 060 registered nasopharyngeal carcinoma patients were followed up for survival outcomes until December 31, 2021. Observed survival rate (OSR) and relative survival rate (RSR) was calculated by Hakulinen method in SURV3.01 software, and Hakulinen's likelihood ratio test was used for statistical difference comparison. Age-standardized relative survival rate (ARSR) was calculated according to the International Cancer Survival Standard (ICSS). Joinpoint 4.7.0.0 software was used to conduct the annual average percentage change (AAPC) in nasopharyngeal carcinoma survival rate. The period from 1972 to 2016 is divided into 9 periods for grouping processing according to 5 years. Results: The OSR of nasopharyngeal carcinoma at 1, 5, 10 years were 63.02%, 34.70% and 24.72%, the RSR at 1, 5, 10 years were 64.44%, 38.98% and 31.64%, respectively. The uptrends of RSR in the nine periods were statistically significant (χ(2)=112.16, P<0.001). The 1, 5, 10 years RSR for males were 62.66%, 35.89% and 27.94%, while the 1, 5, 10 years RSR for females were 68.30%, 45.67% and 39.68%, respectively. There was no statistically significant difference in RSR between males and females (χ(2)=14.16, P=0.656). The 5-year RSR for the age groups of 25-34, 35-44, 45-54, 55-64, 65-74, and over 75 years old were 52.83%, 40.92%, 42.64%, 38.65%, 27.23% and 28.88%, respectively. There was a statistically significant difference in RSR among different age groups (χ(2)=42.33, P=0.003). Moreover, the ARSR of nasopharyngeal carcinoma at 1, 5, 10 years were 63.64%, 37.33% and 27.10%, for males were 61.82%, 35.60% and 25.20%, for females were 68.36%, 43.12% and 32.93%. Period trend showed that the AAPC of 5-ARSR was 2.71% (t=7.47, P<0.001) from 1972 to 2016 in Qidong. The AAPC of 5-ARSR in males and females were 2.63% (t=4.98, P=0.002) and 2.71% (t=6.08, P=0.001). There was statistically significant increase in 5-year ARSR among both genders. Furthermore, the AAPC of 5-year RSR among 25-34, 35-44, 45-54, 55-64, 65-74 and 75+ years old were 2.16% (t=4.28, P=0.004), 3.38% (t=5.06, P=0.001), 1.99% (t=2.82, P=0.026), 2.82% (t=3.39, P=0.012), 2.20% (t=2.82, P=0.026) and -0.91% (t=-0.42, P=0.689), respectively. Except for the 75+ years old age group, the other age groups were significantly upward trend. Conclusions: The overall survival rate of nasopharyngeal carcinoma in Qidong from 1972 to 2016 has shown an upward trend. It is necessary to introduce standardized multi-disciplinary treatment mode to improve treatment effect and survival rate.
Asunto(s)
Humanos , Masculino , Femenino , Anciano , Carcinoma Nasofaríngeo , Tasa de Supervivencia , Pronóstico , Programas Informáticos , Neoplasias Nasofaríngeas , China/epidemiología , IncidenciaRESUMEN
Objective: To report the long-term survival of renal cell carcinoma (RCC) patients treated with radical nephrectomy in Sun Yat-sen University Cancer Center. Methods: We retrospectively analyzed the clinical, pathological and follow-up records of 1 367 non-metastatic RCC patients treated with radical nephrectomy from 1999 to 2020 in this center. The primary endpoint of this study was overall survival rate. Survival curves were estimated using the Kaplan-Meier method, and group differences were compared through Log-rank test. Univariate and multivariate Cox analysis were fit to determine the clinical and pathological features associated with overall survival rate. Results: A total of 1 367 patients treated with radical nephrectomy with complete follow-up data were included in the study. The median follow-up time was 52.6 months, and 1 100 patients survived and 267 died, with the median time to overall survival not yet reached. The 5-year and 10-year overall survival rates were 82.8% and 74.9%, respectively. The 5-year and 10-year overall survival rates of Leibovich low-risk patients were 93.3% and 88.2%, respectively; of Leibovich intermediate-risk patients were 82.2% and 72.3%, respectively; and of Leibovich high-risk patients were 50.5% and 30.2%, respectively. There were significant differences in the long-term survival among the three groups (P<0.001). The 10-year overall survival rates for patients with pT1, pT2, pT3 and pT4 RCC were 83.2%, 73.6%, 55.0% and 31.4%, respectively. There were significant differences among pT1, pT2, pT3 and pT4 patients(P<0.001). The 5-year and 10-year overall survival rates of patients with lymph node metastasis were 48.5% and 35.6%, respectively, and those of patients without lymph node metastasis were 85.1% and 77.5%, respectively. There was significant difference in the long-term survival between patients with lymph node metastasis and without lymph node metastasis. The 10-year overall survival rate was 96.2% for nuclear Grade 1, 81.6% for nuclear Grade 2, 60.5% for nuclear Grade 3, and 43.4% for nuclear Grade 4 patients. The difference was statistically significant. There was no significant difference in the long-term survival between patients with localized renal cancer (pT1-2N0M0) who underwent open surgery and minimally invasive surgery (10-year overall survival rate 80.5% vs 85.6%, P=0.160). Multivariate Cox analysis showed that age≥55 years (HR=2.11, 95% CI: 1.50-2.96, P<0.001), T stage(T3+ T4 vs T1a: HR=2.37, 95% CI: 1.26-4.46, P=0.008), local lymph node metastasis (HR=3.04, 95%CI: 1.81-5.09, P<0.001), nuclear grade (G3-G4 vs G1: HR=4.21, 95%CI: 1.51-11.75, P=0.006), tumor necrosis (HR=1.66, 95% CI: 1.17-2.37, P=0.005), sarcomatoid differentiation (HR=2.39, 95% CI: 1.31-4.35, P=0.005) and BMI≥24kg/m(2) (HR=0.56, 95%CI: 0.39-0.80, P=0.001) were independent factors affecting long-term survival after radical nephrectomy. Conclusions: The long-term survival of radical nephrectomy in patients with renal cell carcinoma is satisfactory. Advanced age, higher pathological stage and grade, tumor necrosis and sarcomatoid differentiation were the main adverse factors affecting the prognosis of patients. Higher body mass index was a protective factor for the prognosis of patients.
Asunto(s)
Humanos , Persona de Mediana Edad , Carcinoma de Células Renales/secundario , Metástasis Linfática , Estudios Retrospectivos , Estadificación de Neoplasias , Neoplasias Renales/patología , Pronóstico , Nefrectomía , Análisis de Supervivencia , Necrosis/cirugía , Tasa de SupervivenciaRESUMEN
Objective: To analyze the survival of nasopharyngeal carcinoma patients in Qidong from 1972 to 2016, and provide a basis for the prognosis evaluation and prevention for nasopharyngeal carcinoma patients. Methods: A total of 1 060 registered nasopharyngeal carcinoma patients were followed up for survival outcomes until December 31, 2021. Observed survival rate (OSR) and relative survival rate (RSR) was calculated by Hakulinen method in SURV3.01 software, and Hakulinen's likelihood ratio test was used for statistical difference comparison. Age-standardized relative survival rate (ARSR) was calculated according to the International Cancer Survival Standard (ICSS). Joinpoint 4.7.0.0 software was used to conduct the annual average percentage change (AAPC) in nasopharyngeal carcinoma survival rate. The period from 1972 to 2016 is divided into 9 periods for grouping processing according to 5 years. Results: The OSR of nasopharyngeal carcinoma at 1, 5, 10 years were 63.02%, 34.70% and 24.72%, the RSR at 1, 5, 10 years were 64.44%, 38.98% and 31.64%, respectively. The uptrends of RSR in the nine periods were statistically significant (χ(2)=112.16, P<0.001). The 1, 5, 10 years RSR for males were 62.66%, 35.89% and 27.94%, while the 1, 5, 10 years RSR for females were 68.30%, 45.67% and 39.68%, respectively. There was no statistically significant difference in RSR between males and females (χ(2)=14.16, P=0.656). The 5-year RSR for the age groups of 25-34, 35-44, 45-54, 55-64, 65-74, and over 75 years old were 52.83%, 40.92%, 42.64%, 38.65%, 27.23% and 28.88%, respectively. There was a statistically significant difference in RSR among different age groups (χ(2)=42.33, P=0.003). Moreover, the ARSR of nasopharyngeal carcinoma at 1, 5, 10 years were 63.64%, 37.33% and 27.10%, for males were 61.82%, 35.60% and 25.20%, for females were 68.36%, 43.12% and 32.93%. Period trend showed that the AAPC of 5-ARSR was 2.71% (t=7.47, P<0.001) from 1972 to 2016 in Qidong. The AAPC of 5-ARSR in males and females were 2.63% (t=4.98, P=0.002) and 2.71% (t=6.08, P=0.001). There was statistically significant increase in 5-year ARSR among both genders. Furthermore, the AAPC of 5-year RSR among 25-34, 35-44, 45-54, 55-64, 65-74 and 75+ years old were 2.16% (t=4.28, P=0.004), 3.38% (t=5.06, P=0.001), 1.99% (t=2.82, P=0.026), 2.82% (t=3.39, P=0.012), 2.20% (t=2.82, P=0.026) and -0.91% (t=-0.42, P=0.689), respectively. Except for the 75+ years old age group, the other age groups were significantly upward trend. Conclusions: The overall survival rate of nasopharyngeal carcinoma in Qidong from 1972 to 2016 has shown an upward trend. It is necessary to introduce standardized multi-disciplinary treatment mode to improve treatment effect and survival rate.
Asunto(s)
Humanos , Masculino , Femenino , Anciano , Carcinoma Nasofaríngeo , Tasa de Supervivencia , Pronóstico , Programas Informáticos , Neoplasias Nasofaríngeas , China/epidemiología , IncidenciaRESUMEN
Objective: To report the long-term survival of renal cell carcinoma (RCC) patients treated with radical nephrectomy in Sun Yat-sen University Cancer Center. Methods: We retrospectively analyzed the clinical, pathological and follow-up records of 1 367 non-metastatic RCC patients treated with radical nephrectomy from 1999 to 2020 in this center. The primary endpoint of this study was overall survival rate. Survival curves were estimated using the Kaplan-Meier method, and group differences were compared through Log-rank test. Univariate and multivariate Cox analysis were fit to determine the clinical and pathological features associated with overall survival rate. Results: A total of 1 367 patients treated with radical nephrectomy with complete follow-up data were included in the study. The median follow-up time was 52.6 months, and 1 100 patients survived and 267 died, with the median time to overall survival not yet reached. The 5-year and 10-year overall survival rates were 82.8% and 74.9%, respectively. The 5-year and 10-year overall survival rates of Leibovich low-risk patients were 93.3% and 88.2%, respectively; of Leibovich intermediate-risk patients were 82.2% and 72.3%, respectively; and of Leibovich high-risk patients were 50.5% and 30.2%, respectively. There were significant differences in the long-term survival among the three groups (P<0.001). The 10-year overall survival rates for patients with pT1, pT2, pT3 and pT4 RCC were 83.2%, 73.6%, 55.0% and 31.4%, respectively. There were significant differences among pT1, pT2, pT3 and pT4 patients(P<0.001). The 5-year and 10-year overall survival rates of patients with lymph node metastasis were 48.5% and 35.6%, respectively, and those of patients without lymph node metastasis were 85.1% and 77.5%, respectively. There was significant difference in the long-term survival between patients with lymph node metastasis and without lymph node metastasis. The 10-year overall survival rate was 96.2% for nuclear Grade 1, 81.6% for nuclear Grade 2, 60.5% for nuclear Grade 3, and 43.4% for nuclear Grade 4 patients. The difference was statistically significant. There was no significant difference in the long-term survival between patients with localized renal cancer (pT1-2N0M0) who underwent open surgery and minimally invasive surgery (10-year overall survival rate 80.5% vs 85.6%, P=0.160). Multivariate Cox analysis showed that age≥55 years (HR=2.11, 95% CI: 1.50-2.96, P<0.001), T stage(T3+ T4 vs T1a: HR=2.37, 95% CI: 1.26-4.46, P=0.008), local lymph node metastasis (HR=3.04, 95%CI: 1.81-5.09, P<0.001), nuclear grade (G3-G4 vs G1: HR=4.21, 95%CI: 1.51-11.75, P=0.006), tumor necrosis (HR=1.66, 95% CI: 1.17-2.37, P=0.005), sarcomatoid differentiation (HR=2.39, 95% CI: 1.31-4.35, P=0.005) and BMI≥24kg/m(2) (HR=0.56, 95%CI: 0.39-0.80, P=0.001) were independent factors affecting long-term survival after radical nephrectomy. Conclusions: The long-term survival of radical nephrectomy in patients with renal cell carcinoma is satisfactory. Advanced age, higher pathological stage and grade, tumor necrosis and sarcomatoid differentiation were the main adverse factors affecting the prognosis of patients. Higher body mass index was a protective factor for the prognosis of patients.
Asunto(s)
Humanos , Persona de Mediana Edad , Carcinoma de Células Renales/secundario , Metástasis Linfática , Estudios Retrospectivos , Estadificación de Neoplasias , Neoplasias Renales/patología , Pronóstico , Nefrectomía , Análisis de Supervivencia , Necrosis/cirugía , Tasa de SupervivenciaRESUMEN
El abordaje nutricional en los recién nacidos de muy bajo peso al nacimiento constituye un desafío en la práctica clínica de los neonatólogos, y muchas veces se aborda fuera del período crítico. Existe evidencia contundente de que la optimización nutricional precoz impacta en forma directamente proporcional en la sobrevida y sobrevida sin morbilidades mayores para este grupo. La implementación de lactancia materna precoz en este contexto debe ser una prioridad del equipo asistencial, siendo la mejora de calidad una herramienta de demostrada utilidad para mejorar los resultados en términos de mortalidad y morbilidad neonatal.
The nutritional approach of the very low birth weight infant poses a great challenge to most neonatologists in their clinical practice, and it is frequently delayed until de newborn is in stable clinical conditions. Currently, scientific evidence supports that early nutritional optimization impacts directly on this group's survival and on their survival without major morbidities. Initiatives fostering early breastfeeding should be prioritized by the healthcare team. Quality improvement has shown to be a very useful resource to improve outcomes regarding neonatal mortality and morbidities.
A abordagem nutricional do recém-nascido de muito baixo peso representa um grande desafio para a maioria dos neonatologistas em sua prática clínica, sendo frequentemente postergada até que o recém-nascido esteja em condições clínicas estáveis. Atualmente, evidências científicas sustentam que a otimização nutricional precoce impacta diretamente na sobrevivência desse grupo e na sobrevivência sem maiores morbidades. Iniciativas de incentivo ao aleitamento materno precoce devem ser priorizadas pela equipe de saúde. A melhoria da qualidade tem se mostrado um recurso muito útil para melhorar os desfechos em relação à mortalidade e morbidades neonatais.
Asunto(s)
Humanos , Recién Nacido , Lactante , Calidad de la Atención de Salud/normas , Lactancia Materna , Recien Nacido Prematuro , Recién Nacido de muy Bajo Peso , Mortalidad Infantil , Tasa de Supervivencia , Mejoramiento de la Calidad , Muerte del Lactante/prevención & controlRESUMEN
Introduction: The relationship between the tumor inflammatory infiltrate, also known as tumor-infiltrating lymphocytes (TILs), and invasive breast carcinomas has been extensively studied in recent years to verify its association with prognosis and response to treatment. The goal of this study was to associate the presence of TILs with patient's survival time. Methods: We studied prognostic clinicopathological characteristics already established in the literature and their impact on overall five-year survival time of patients with invasive breast cancer treated at Hospital Santa Casa in Belo Horizonte, Minas Gerais, Brazil, in 2011 (n=290). This was an observational and retrospective study. Results: The presence of TILs was associated with tumors of no special type (p=0.018) and with younger age of the patients (p=0.042). Smaller tumor size (HR: 19.24; 95%CI 4.3086.15; p<0.001), absence of metastasis to the axillary lymph nodes (HR: 2.80; 95%CI 1.027.70; p=0.002), positivity for progesterone receptor (HR: 0.39; 95%CI 0.170.87; p=0.022), and presence of TILs (HR: 0.23; 95%CI 0.080.65; p=0.005) were associated with longer survival times. Conclusions: This study suggests that the presence of TILs, along with other clinicopathological characteristics, is a prognostic factor in breast cancer
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Neoplasias de la Mama/mortalidad , Linfocitos Infiltrantes de Tumor/metabolismo , Pronóstico , Inmunohistoquímica , Biomarcadores de Tumor/sangre , Tasa de Supervivencia , Estudios RetrospectivosRESUMEN
INTRODUÇÃO: O carcinoma de células escamosas da cavidade oral (CEC) abrange uma ampla diversidade de células neoplásicas que possuem características moleculares heterogêneas quando expressadas pelo tumor, cuja detecção primária pode se tornar uma ferramenta útil tanto no diagnóstico inicial quanto no prognóstico nos pacientes portadores deste câncer. Os principais biomarcadores tumorais (BmTs) descritos e associados à carcinogênese do câncer de cavidade oral são: p53, p16, Ciclina-D1, EGFR e a E-caderina. OBJETIVO: O objetivo deste estudo foi avaliar o risco de recorrência a partir da detecção dos BmTs p16, p53, E-caderina, Ciclina-D1 e EGFR nos pacientes portadores de CEC submetidos ao tratamento multimodal. MATERIAL E MÉTODOS: Foram selecionados 100 pacientes com diagnóstico de CEC de cavidade oral e submetidos ao tratamento multimodal, os quais foram separados em dois grupos: A) Pacientes com CEC de assoalho de boca; B) Pacientes com CEC de língua, ambos os grupos tratados de forma multimodal. Após seleção foi realizada a análise por imunoistoquímica (IHQ) da expressão dos 05 biomarcadores acima descritos. Da mesma forma, foi realizada a análise dos dados demográficos e clínicos, além dos critérios morfológicos inerentes ao tumor para determinação dos fatores preditivos e prognósticos independentes. RESULTADOS: Após a análise retrospectiva dos dados da população de estudo, 51 pacientes (51%) apresentaram CEC na região do assoalho de boca e 49 (49%) na língua, com maior proporção de homens do que mulheres (69 % vs. 31%) e com idade maior ou igual a 60 anos (mediana: 62 anos/ R: 29-86 anos). A mediana de acompanhamento dos pacientes foi de 28 meses (R: 0-71 meses/média: 26 /DP: +-14,04) e do aparecimento da recorrência foi de 12 meses (mediana: 9 meses/ R: 0-37 meses). A maioria apresentou o estadiamento clínico-patológico inicial I e II (63,6%), pior padrão de infiltração tipo 3-5 (70,5%) e com presença de extensão extracapsular (EEC) (57,5%). Por outro lado, 21 pacientes (21,2%) expressaram p16, 87 (87,9%) a Ciclina-D1, 63 (63%) p53, 53 (53,5%) a E-caderina e 66 (66%) o EGFR. Após aplicação do teste Qui-quadrado foi observada associação estatisticamente significativa entre a expressão do p53 e o sexo (p: 0,01), p53 e tabagismo/etilismo (p: 0,04) e a expressão da E-caderina associada à presença de infiltrado linfoide (p: 0,03). Para análise da Sobrevida Global (SG) foi aplicado o teste de Kaplan Meier, sendo que a média foi de 53 meses (R: 42-61 meses). Na análise da Sobrevida Livre de Doença (SLD) a média foi de 31 meses (R: 27-24 meses). Finalmente, foi realizada a análise multivariada de Cox para cálculo da razão de risco (RR), onde foram observados para o EGFR RR: 4,97 (p: 0,016/R: 1,34-18,30) e a E-caderina RR: 0,294 (p: 0,056/ R: 0.084-1.03). CONCLUSÃO: A expressão de EGFR resultou como potencial biomarcador preditivo de risco de recorrência nos pacientes com CEC de cavidade oral e submetidos à abordagem multimodal, enquanto a E-caderina comportou-se como provável fator protetor contra o risco de recorrência neste mesmo grupo. Contudo, uma avaliação com maior coorte de pacientes se torna necessária para melhor compreensão do papel de outros BmTs, bem como a validação destes resultados na prática clínica.
INTRODUCTION: Oral Squamous Cell Carcinoma (OSCC) is the sixth most common cancer worldwide, characterized by heterogeneous cellular and histological features observed by different molecular parameters. The main biomarkers (BKs) associated with oral cavity tumorigenesis are p53, EGFR, Cyclin-D1, p16 and E-cadherin and their expression is associated with poor prognosis and multiples relapses, besides other histopathological prognostic factors associated to lower rates of overall (OS) and disease-free survival (DFS). OBJECTIVE: This study aims to confirm through histopathological assessment (HP) based on morphological tumor criteria and immunohistochemistry analysis (IHC) of the BKs the association with increased local recurrence in patients diagnosed with OSCC submitted to multimodal treatment at A.C. Camargo Cancer Center. MATERIAL AND METHODS: One hundred patients diagnosed with OSCC submitted to multimodal treatment during 2013-2017 were evaluated and distributed in two groups according to the primary local tumor: A) Patients with OSCC in the floor of the mouth and B) tongue OSCC, both groups treated with only surgery, surgery plus radiotherapy (RT) and/or surgery with RT and chemotherapy. IHC and HP analysis were performed of surgical specimen for detection of these five BKs such as EGFR, p53, E-cadherin, p16 and Cyclin D1. Moreover, after HP for morphological tumor featuring prognostic factors such as clinic-pathological staging, free surgical margins, extracapsular extension of lymph nodes, perineural and angiolymphatic invasion, depth of pattern infiltration were described. Demographic and clinical data were collected, and the nonparameter Chi-square statistical test was performed for determining association between them. OS and DFS rates were calculated using Kaplan Meier test and logRank test for univariate statistical analysis. Cox regression model was done, and the hazard ratio was established for each independent factor to predict clinical failure (p<=0.05). RESULTS: From 100 patients analyzed, 61% were male and 39% female. Regarding local primary tumor, 51% presented OSCC in the floor of the mouth and 49% in the tongue with a mean age of 62 years (R: 29-86). The median of follow-up was 28 months (mean: 26 / SD: +-14,04 / R: 0-71) and the mean of recurrence appearance was 12 months (median: 9/ R: 0-37). Most patients showed an initial stage (I-II) (63.6%), Worst pattern of invasion (WPOI) 3-5 (70.5%), extracapsular extension (EE) (57.5%). Regarding BKs expression, 21.2% p16, 87.9% Cyclin-D1, 63% p53, 53.5% E-cadherin, and 66% EGFR. It was observed a statistically significant association between p53 expression and for both sex (p: 0.01), p53 and smoking/alcohol consumption (p:0.04). E-cadherin was associated with lymph node infiltration (p: 0.03). The median OS was 80% vs 60% in 03 years (R: 42-61; I/II vs. III-IV p: 0.06); for DFS was 50% (p:0.22; I/II vs. III/IV) in 05 years (R: 27-24). Cox regression showed that EGFR expression HR: 4.9 (p: 0.02/ R: 1.34-18.30) and E-cadherin HR: 0.3 (p: 0.06/R: 0.084-1.03) and EE as morphological tumor criteria (HR: 3.68 / p: 0.056 / R: 1.00-13.48) are independent factors for prediction of clinical failure. CONCLUSION: EGFR expression is a potential biomarker for prediction of oral cancer recurrence in patients submitted to multimodal management; however, the loss of E-cadherin expression was considered as a protective factor against OSCC recurrence for this group. Furthermore, longitudinal studies must be performed to validate these results in the clinical practice
Asunto(s)
Neoplasias de la Boca , Biomarcadores de Tumor , Recurrencia , Tasa de Supervivencia , Carcinoma de Células Escamosas de Cabeza y Cuello , Neoplasias de Cabeza y CuelloRESUMEN
Objective: To investigate the clinicopathological features and prognostic factors of lung metastasis in patients with cervical cancer after treatment. Methods: The clinicopathological data of 191 patients with lung metastasis of stage Ⅰa-Ⅲb cervical cancer (FIGO 2009 stage) treated in Sichuan Cancer Hospital from January 2007 to December 2020 were analyzed retrospectively. Kaplan Meier method and Log rank test were used for survival analysis, and Cox regression model was used for prognostic factors analysis. Results: Among 191 patients with lung metastasis of cervical cancer, pulmonary metastasis was found in 134 patients (70.2%) during follow-up examination, and 57 patients (29.8%) had clinical symptoms (cough, chest pain, shortness of breath, hemoptysis, and fever). The time from the initial treatment of cervical cancer to the discovery of lung metastasis was 1-144 months in the whole group, with a median time of 19 months. Univariate analysis of the prognosis of lung metastasis after treatment of cervical cancer showed that the diameter of cervical tumor, lymph node metastasis, positive surgical margin, disease-free interval after treatment of cervical cancer, whether it is accompanied by other metastasis, the number, location and maximum diameter of lung metastasis, and the treatment method after lung metastasis are related to the prognosis of patients with lung metastasis of cervical cancer. Multivariate analysis showed that the number of lung metastases and other site metastases in addition to lung metastases were independent factors affecting the prognosis of patients with lung metastases of cervical cancer (P<0.05). Conclusions: For patients with cervical cancer, attention should be paid to chest CT examination during follow-up to guard against the possibility of lung metastasis after treatment. Besides lung metastasis, other site metastasis and the number of lung metastasis are independent factors affecting the prognosis of patients with lung metastasis of cervical cancer. For patients with lung metastasis after treatment of cervical cancer, surgical treatment is an effective treatment. It is necessary to strictly grasp the surgical indications, and some patients can achieve long-term survival. For patients with lung metastasis of cervical cancer who are not suitable for resection of lung metastasis, the remedial treatment of chemotherapy with or without radiotherapy is still a recommended choice.
Asunto(s)
Femenino , Humanos , Pronóstico , Neoplasias del Cuello Uterino/patología , Estadificación de Neoplasias , Estudios Retrospectivos , Neoplasias Pulmonares/patología , Tasa de SupervivenciaRESUMEN
Objective@#This study determined the treatment outcomes of patients with retinoblastoma seen at a Philippine tertiary government hospital from January 2000 to January 2020.@*Method@#This is a cohort study. Medical records of patients with histopathologic-proven retinoblastoma were reviewed and pertinent information on clinical profile and presentation, treatment and outcomes were recorded.@*Results@#This study included 118 patients (146 eyes) with mean age at symptom onset of 7.4 + 6.6 months and mean age at consult of 11.5 + 13.7 months. There were 69 (47%) eyes with International Classification of Retinoblastoma (ICRB) stage E. The most common primary treatment was enucleation (n=137, 94%). The most common high-risk histopathologic feature was involvement of the optic nerve at the cut-end section (n=27, 34%). Only 14 patients (11%) completed treatment with median follow-up of 30.5 months (range 4- 122). @*Conclusion@#The rate of overall survival of patients with retinoblastoma is low in this study, similar to other developing countries. This can be due to higher proportion of patients with advanced stage at presentation and lower percentage of treatment completion. Early diagnosis and treatment may lead to better survival rate, visual outcome and quality of life. Due to limited data on follow-up, globe preservation could not be determined.
Asunto(s)
Retinoblastoma , Tasa de SupervivenciaRESUMEN
Introduction: Childhood cancer is a small proportion of all cancers but is still a major public health problem. Objective: To describe the 5-year incidence and mortality rates and net survival of childhood cancer in Uruguay. Method: Data on all malignant tumors diagnosed in children aged 0-14 were included for the period 2011-2015, obtained from the National Pediatric Registry of Cancer and from the Ministry of Health Mortality Registry, classified according to the International Classification of Childhood Cancer (ICCC-3). Information on the total population was obtained from national census records. Follow up was made until December 2020. Results: The standardized incidence rate was 128/million children per year. The distribution of the disease was similar to developed countries. The overall mortality rate was 28.2/million, with a net overall survival of 79.6% for the total population. Conclusion: Childhood cancer incidence in Uruguay is similar to developed countries. Progress in diagnosis and care have improved survival immensely, but efforts must continue to keep this trend and ameliorate the outcomes.
Introdução: O câncer em crianças representa uma pequena proporção de todos os cânceres, mas continua a ser um importante problema de saúde pública. Objetivo: Descrever a incidência e a mortalidade, bem como a sobrevida do câncer infantil no Uruguai por um período de cinco anos. Método: Foram incluídos todos os tumores malignos diagnosticados em crianças de 0 a 14 anos de 2011 a 2015. Os dados foram obtidos do Registro Nacional de Câncer e dos Registros de Mortalidade do Ministério da Saúde. Os casos foram classificados de acordo com a International Classification of Childhood Cancer (ICCC-3). A informação total sobre a população foi obtida a partir de registros do censo nacional. O acompanhamento foi feito até dezembro de 2020. Resultados: A taxa de incidência padronizada foi de 128/milhão de crianças por ano. A distribuição foi semelhante à dos países industrializados. A taxa de mortalidade global foi de 28,2/milhão, com sobrevida global líquida de 79,6% para a população total. Conclusão: A incidência de câncer infantil no Uruguai é semelhante à dos países desenvolvidos. Os avanços no diagnóstico e no atendimento melhoraram substancialmente a sobrevida, mas os esforços devem continuar para se obter melhores resultados.
Introducción: El cáncer en los niños constituye una pequeña proporción de todos los cánceres pero continúa siendo un importante problema de salud pública. Objetivo: Describir la incidencia y mortalidad, así como la sobrevida neta del cáncer infantil en nuestro país durante cinco años. Método: Se incluyeron todos los tumores malignos diagnosticados en niños entre 0 y 14 años desde 2011 a 2015. Los datos se obtuvieron del Registro Nacional del Cáncer así como de los Registros de Mortalidad del Ministerio de Salud. Los casos se clasificaron de acuerdo con International Classification of Childhood Cancer (ICCC-3). La información de la población total fue obtenida de los registros nacionales de censo. El seguimiento se hizo hasta diciembre de 2020. Resultados: La tasa de incidencia estandarizada fue de 128/millón de niños por año. La distribución fue similar a la de los países industrializados. La tasa de mortalidad global fue de 28,2/millón, con una sobrevida global neta de 79,6% para el grupo total. Conclusión: La incidencia de cáncer infantil en Uruguay es similar a la de los países desarrollados. Los avances en el diagnóstico y el cuidado han mejorado notablemente la sobrevida, pero se deben continuar los esfuerzos para seguir mejorando los resultados.
Asunto(s)
Niño , Mortalidad Infantil , Tasa de Supervivencia , Neoplasias , UruguayRESUMEN
Peritoneal tumours have a large population and a poor prognosis with limited therapeutic options available, and are common originated from gastric, colorectal, appendix and other cancers. Traditionally, peritoneal tumours have long been considered to be a terminal condition with a median survival of 3-6 months, and the palliative symptomatic treatment is recommended. Recently, the multimodal therapeutic strategy of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has resulted in more effective on the prevention and treatment of peritoneal metastasis, which can significantly improve the survival and quality of life. Under the guidance of the China Anti-Cancer Association (CACA), the "CACA Guidelines for Holistic Integrative Management of Cancer-Peritoneal Tumours" was jointly completed by experts in related fields organized by the Chinese Society of Peritoneal Oncology. This guideline is guided by the concept of integrative medicine and focuses on the domestic epidemiology, genetic background and original studies. It emphasizes the multidisciplinary team to holistic integrative medicine (MDT to HIM), and pays attention to the whole-course management of "prevention, screening, diagnosis, treatment, and rehabilitation". This guideline mainly focuses on peritoneal metastasis from gastrointestinal tumours, aiming to standardize the clinical diagnosis and treatment process, and jointly promote the management of peritoneal metastasis in China.
Asunto(s)
Humanos , Neoplasias Peritoneales/secundario , Terapia Combinada , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Calidad de Vida , Pronóstico , Hipertermia Inducida/métodos , Tracto Gastrointestinal , Neoplasias Colorrectales/patología , Procedimientos Quirúrgicos de Citorreducción/métodos , Tasa de SupervivenciaRESUMEN
Hepatocellular carcinoma (HCC) is one of the most common malignancies and a leading cause of cancer-related death worldwide. Surgery remains the primary and most successful therapy option for the treatment of early- and mid-stage HCCs, but the high heterogeneity of HCC renders prognostic prediction challenging. The construction of relevant prognostic models helps to stratify the prognosis of surgically treated patients and guide personalized clinical decision-making, thereby improving patient survival rates. Currently, the prognostic assessment of HCC is based on several commonly used staging systems, such as Tumor-Node-Metastasis (TNM), Cancer of the Liver Italian Program (CLIP), and Barcelona Clinic Liver Cancer (BCLC). Given the insufficiency of these staging systems and the aim to improve the accuracy of prognostic prediction, researchers have incorporated further prognostic factors, such as microvascular infiltration, and proposed some new prognostic models for HCC. To provide insights into the prospects of clinical oncology research, this review describes the commonly used HCC staging systems and new models proposed in recent years.
Asunto(s)
Humanos , Carcinoma Hepatocelular/patología , Neoplasias Hepáticas/patología , Pronóstico , Estadificación de Neoplasias , Tasa de Supervivencia , Estudios RetrospectivosRESUMEN
OBJECTIVE@#To investigate the survival of patients with cardiac arrest and cardiopulmonary resuscitation (CA-CPR), and to analyze the factors influencing survival at 30 days after restoration of spontaneous circulation (ROSC).@*METHODS@#A retrospective cohort study was conducted. Clinical data of 538 patients with CA-CPR admitted to the People's Hospital of Ningxia Hui Autonomous Region from January 2013 to September 2020 were enrolled. The gender, age, underlying disease, cause of CA, type of CA, initial rhythm, presence or absence of endotracheal intubation, defibrillation, use of epinephrine, and 30-day survival rate of patients were collected. The etiology of CA and 30-day survival rate among patients with different ages were compared, as well as the clinical data between patients who survived and died at 30 days after ROSC were also compared. Multivariate Logistic regression was used to analyze the relevant factors affecting the 30-day survival rate of patients.@*RESULTS@#Among 538 patients with CA-CPR, 67 patients with incomplete information were excluded, and 471 patients were enrolled. Among 471 patients, 299 were males and 172 were females. Aged from 0 to 96 years old, 23 patients (4.9%) were < 18 years old, 205 patients (43.5%) were 18 to 64 years old, and 243 patients (51.6%) were ≥ 65 years old. 302 cases (64.1%) achieved ROSC, and 46 patients (9.8%) survived for more than 30 days. The 30-day survival rate of patients aged < 18 years old, 18-64 years old and ≥ 65 years old was 8.7% (2/23), 12.7% (26/205) and 7.4% (18/243), respectively. The main causes of CA in patients younger than 18 years were severe pneumonia (13.1%, 3/23), respiratory failure (13.1%, 3/23), and trauma (13.1%, 3/23). The main causes were acute myocardial infarction (AMI; 24.9%, 51/205), respiratory failure (9.8%, 20/205), and hypoxic brain injury (9.8%, 20/205) in patients aged 18-64 years old, and AMI (24.3%, 59/243) and respiratory failure (13.6%, 33/243) in patients aged ≥ 65 years old. Univariate analysis results revealed that the 30-day survival rate of patients with CA-CPR may be related to the the cause of CA was AMI, initial rhythm was ventricular tachycardia/ventricular fibrillation, endotracheal intubation and epinephrine. Multivariate Logistic regression analysis results showed that CA was caused by AMI [odds ratio (OR) = 0.395, 95% confidence interval (95%CI) was 0.194-0.808, P = 0.011] and endotracheal intubation (OR = 0.423, 95%CI was 0.204-0.877, P = 0.021) was a protective factor for 30 days of survival after ROSC in patients with CA-CPR.@*CONCLUSIONS@#The 30-day survival rate of CA-CPR patients was 9.8%. The 30-day survival rate of CA-CPR patients with AMI after ROSC is higher than that of patients with other CA causes, and early endotracheal intubation can improve the prognosis of patients.
Asunto(s)
Femenino , Masculino , Humanos , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Estudios Retrospectivos , Tasa de Supervivencia , Paro Cardíaco , Hospitales , Epinefrina , Fibrilación VentricularRESUMEN
Acute-on-chronic liver failure (ACLF) is a clinical syndrome of acute decompensation accompanied by organ failure that occurs on the basis of chronic liver disease and has a high short-term mortality rate. Currently, there are still differences in relation to the definition of ACLF; thus, baseline characteristics and dynamic changes are important bases for clinical decision-making in patients with liver transplantation and others. The basic strategies for treating ACLF currently include internal medicine treatment, artificial liver support systems, and liver transplantation. Multidisciplinary active collaborative management throughout the whole course is of great significance for further improving the survival rate in patients with ACLF.
Asunto(s)
Humanos , Trasplante de Hígado , Insuficiencia Hepática Crónica Agudizada/complicaciones , Tasa de Supervivencia , Cirrosis Hepática/complicaciones , PronósticoRESUMEN
Objective: To analyze the incidence and survival rate of liver cancer cases in the entire population in the Qidong region from 1972 to 2019, so as to provide a basis for prognosis evaluation, prevention, and treatment. Methods: The observed survival rate (OSR) and relative survival rate (RSR) of 34 805 cases of liver cancer in the entire Qidong region population from 1972 to 2019 were calculated using Hakulinen's method with SURV3.01 software. Hakulinen's likelihood ratio test was used for statistical analysis. Age-standardized relative survival (ARS) was calculated using the International Cancer Survival Standard. The Joinpoint regression analysis was performed with Joinpoint 4.7.0.0 software to calculate the average annual percentage change (AAPC) of the liver cancer survival rate. Results: 1-ASR increased from 13.80% in 1972-1977 to 50.20% in 2014-2019, while 5-ASR increased from 1.27% in 1972-1977 to 27.64% in 2014-2019. The upward trend of RSR over eight periods was statistically significant (χ (2) = 3045.29, P < 0.001). Among them, male 5-ASR was 0.90%, 1.80%, 2.33%, 4.92%, 5.43%, 7.05%, 10.78%, and 27.78%, and female 5-ASR was 2.33%, 1.51%, 3.35%, 3.92%, 3.84%, 7.18%, 11.45%, and 29.84%, respectively. There was a statistically significant difference in RSR between males and females (χ (2) = 45.68, P < 0.001). The 5-RSR for each age group of 25-34 years old, 35-44 years old, 45-54 years old, 55-64 years old, 65-74 years old, and 75 years old were 4.92%, 5.29%, 8.17%, 11.70%, 11.63%, and 9.60%, respectively. There were statistically significant differences in RSR among different age groups (χ (2) = 501.29, P < 0.001). The AAPC in Qidong region from 1972 to 2019 for 1-ARS, 3-ASR, and 5-ARS were 5.26% (t = 12.35, P < 0.001), 8.10% (t = 15.99, P < 0.001), and 8.96 % (t = 16.06, P < 0.001), respectively. The upward trend was statistically significant in all cases. The AAPC of 5-ARS was 9.82% in males (t = 14.14, P < 0.001), and 8.79% in females (t = 11.48, P < 0.001), and the upward trend was statistically significant in both. The AAPC of 25-34 years old, 35-44 years old, 45-54 years old, 55-64 years old, 65-74 years old, and 75 years old were 5.37% (t = 5.26, P = 0.002), 5.22% (t = 5.66, P = 0.001), 7.20% (t = 6.88, P < 0.001), 10.00% (t = 12.58, P < 0.001), 9.96% (t = 7.34, P < 0.001) and 8.83% (t = 3.51, P = 0.013), and the upward trend was statistically significant. Conclusion: The overall survival rate of registered cases of liver cancer in the Qidong region's entire population has greatly improved, but there is still much room for improvement. Hence, constant attention should be paid to the study on preventing and treating liver cancer.